The ErbB2 receptor tyrosine kinase (RTK) is expressed in basal cells of squamous epithelia and the outer root sheath of hair follicles. We previously showed that constitutive expression of activated ErbB2 directed to these sites in the skin by the keratin 14 (K14) promoter produces prominent hair follicle abnormalities and striking skin hyperplasia in transgenic mice. However, perinatal lethality precluded the establishment of a transgenic line for analysis of ErbB2 function in adult animals. To investigate the signi®cance of ErbB2 signaling in epithelial tissues during and post development, we developed a K14-rtTA/TetRE-ErbB2`Tet-On' bitransgenic mouse system. These mice were normal until the ErbB2 transgene was induced by exposure to doxycycline (Dox). Prenatal induction resulted in perinatal death. Postnatally, ErbB2 transgene expression was observed at 4 h after the initiation of Dox, and reached a plateau at 24 h. Skin hyperplasia followed after 2 days and these changes reverted to normal upon Dox withdrawal. In adults, as in the neonates, prolonged ErbB2 induction caused prominent skin and hair follicle hyperplasias. Severe hyperplasias in the cornea, eye lids, tongue and esophagus were also observed. ErbB2 transgene induction was accompanied by increased expression of TGFa, a ligand of epidermal growth factor receptor (EGFR), and to a lesser extent, EGFR, further enhancing RTK signal transduction. We conclude that ErbB2 plays important roles in both development and maintenance of hair follicles and diverse squamous epithelia and that this ligand-inducible and tissue-speci®c Tet-On' transgenic mouse system provides a means to study transgenes with perinatal toxicity.
Introduction
The epidermal growth factor receptor (EGFR) belongs to a superfamily of receptor tyrosine kinases (RTK) that include ErbB2, ErbB3 and ErbB4 (for review, see Carraway and Cantley, 1994; Dougall et al., 1994) . EGFR and its ligands EGF and TGFa, have been shown to be important in skin and hair follicle development (Vassar and Fuchs, 1991; Luetteke et al., 1993; Mann et al., 1993; Miettinen et al., 1995; Murillas et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995; Wang et al., 1994; Xie et al., 1998) . There is increasing evidence that the members of the ErbB family cooperate in the regulation of cellular functions (for review, see Carraway and Cantley, 1994; Dougall et al., 1994) . The rat c-neu/erbB2 gene encodes a 185 kDa transmembrane glycoprotein (Padhy et al., 1982) with considerable sequence homology to the EGFR (Bargmann et al., 1986) but its ligand has not been de®nitively identi®ed. The endogenous ErbB2 is expressed in the basal cells of the epidermis (Kokai et al., 1987) and the outer root sheath (ORS) of the hair follicles (Maguire et al., 1989) . The expression levels of ErbB2 are generally higher in fetal tissues than in the corresponding adult tissues (Press et al., 1990) , suggesting a role for ErbB2 signaling in the development of the skin and hair follicles. To delineate the roles of ErbB2 in epidermal development, we previously created transgenic mice in which activated ErbB2 was expressed in the skin under the control of human keratin 14 (K14) promoter (Xie et al., 1998) . This strategy directed increased ErbB2 signaling to the cells in which it is normally expressed. All the K14-ErbB2 transgenic founder mice exhibited dramatic disruption in hair follicle morphogenesis. The majority of the hair follicles were replaced by hyperproliferative intradermal squamous invaginations, while the remaining follicles exhibited severe hyperplasia and disorganization. These observations suggest an important role for this RTK in epidermal growth, dierentiation and hair follicle morphogenesis. However, all but one of the transgenic founder mice died before or shortly after birth, probably as a consequence of defects in the skin and esophagus. Consequently, no transgenic mouse line was established to permit a detailed analysis of ErbB2 functions in the maintenance of hair follicles and epidermis in adult animals.
In this report, we describe the development of a Tet-On transgenic mouse system (Furth et al., 1994; Kistner et al., 1996) , in which the expression of the activated ErbB2 in the epidermis and other strati®ed epithelia was induced only in the presence of doxycycline (Dox) either in utero or postnatally. The transgene induction was rapid and reversible over a relatively short duration. More prolonged induction of the activated ErbB2 caused striking hyperplasia in the diverse strati®ed epithelial tissues such as skin, cornea, tongue, and esophagus. These animals soon died, probably due to an inability to ingest food. Interestingly, TGFa and EGFR were also upregulated, further enhancing RTK signaling. Our results suggest that ErbB2 is not only important during the morphogenesis of hair follicles and epidermis as indicated in our previous K14-ErbB2 models, but that ErbB2 signaling might also contribute to the maintenance of the additional strati®ed epithelia.
Results

Generation of transgenic mice
Two lineages of transgenic mice were generated; one transgene (K14-rtTA) expresses the reverse tetracycline-responsive transcriptional activator (rtTA) driven by the 2.3 kb human K14 promoter (Xie et al., 1998) ; the other transgene (TetRE-ErbB2) encodes the activated form of rat ErbB2 (Shih et al., 1981) under the control of a minimal promoter and the tetracycline responsive element (TetRE) (Figure 1a) . A total of ®ve founder mice positive for K14-rtTA transgene, and four positive for TetRE-ErbB2 transgene were identi®ed by PCR using a pair of oligonucleotides speci®c for the K14-rtTA transgene, or the TetREErbB2 transgene, respectively. The integrity of the transgenes was con®rmed by Southern blot analysis ( Figure 1b ) using a transgene speci®c probe directed at the SV40 sequence common to both transgenes. Initial screening con®rmed that rtTA mRNA was expressed in the epidermis of K14-rtTA line 3-8, as judged by RT ± PCR using skin RNA (data not shown). K14-rtTA line 3-8 and TetRE-ErbB2 line 8-4 were used in most of the crossbreeding experiments to generate bitransgenic animals. Similar results were obtained when another TetRE-ErbB2 line (line 1-1) was utilized for crossbreeding (data not shown). The rtTA is expected to be expressed, under K14 direction, constitutively and exclusively in the basal cells of the squamous epithelia and in the outer root sheath of the hair follicles (Xie et al., 1998) . We also anticipate that rtTA, expressed in a tissue-speci®c manner, binds to TetRE only in the presence of Dox (Tet-On), and speci®cally induces the expression of the transgene that encodes activated ErbB2.
Skin abnormalities, blindness, cachexia, and premature death caused by prolonged induction with doxycycline Unlike the previous K14-ErbB2 transgenic mice, the bitransgenic ospring, in the absence of Dox administration during pregnancy, showed no sign of abnormalities compared to their littermates with a single transgene, or without a transgene, in all stages of the development (Figure 2 , and data not shown). However, maternal administration of Dox beginning in middle to late gestation (10 ± 18 d.p.c.) resulted in a stillbirth rate of about 50% among the bitransgenic neonates. All live-birth bitransgenic ospring died within 24 h and the aected animals exhibited palelooking thickened skin, but no noticeable skin wrinkles Figure 1 The Tet-On inducible transgenic mouse system and Southern blot analysis of transgenic mice. (a) A schematic outline of the K14-rtTA/TetRE-ErbB2 two-component Tet-On transgenic mouse system. The K14-rtTA transgene directs expression of the reverse tetracycline transcriptional activator (rtTA) to the epidermis. The binding of rtTA to the tetracycline responsive element (TetRE) and the induction of the transgene ErbB2 should only occur in the presence of Doxycycline (Dox). (b and c) Southern blot analysis of the TetRE-ErbB2, and the K14-rtTA transgenic mice, respectively. Genomic DNA extracted from a tail biopsy from each transgenic founder mouse (TG3-8 for K14-rtTA, or TG8-4 for TetRE-ErbB2, respectively) or their nontransgenic control littermates was digested with SalI, and subjected to Southern blot analysis. 100 pg of each transgene fragment excised from the original transgene-containing plasmids was loaded as a positive control. The ®lter was probed with a 32 P-labeled SV40 SalI ± EcoRI fragment speci®c for both transgenes ErbB2 induces reversible skin hyperplasia and TGFa W Xie et al (data not shown). These skin features and the perinatal death were identical to those observed in the K14-ErbB2 transgenic founder mice (Xie et al., 1998) . These newborns exhibited restricted movement and an inability to suckle, perhaps contributing to the perinatal death. Postnatally, exposure to Dox during lactation or after weaning also caused a striking skin phenotypes. Starting on day 2 or 3 after Dox induction, the bitransgenic mice began to display hyperplastic and wrinkled skin. The skin wrinkles were particularly prominent when the animals were around 10 days of age, aecting virtually all body sites. This feature was most severe on the head surrounding the snout and eyelids, on the foot pads and genital region. The entire skin abnormality could be reversed if Dox was removed within 2 ± 3 days.
Besides these skin abnormalities, prolonged postnatal exposure to Dox also caused cachexia. The animals stopped gaining weight within 2 ± 3 days of induction such that they became markedly underweight after 4 ± 7 days of induction during lactation (14-, and 16-day-old mice) or after weaning (28-dayold mouse) (Figure 2 ). These animals became very frail, exhibiting reduced movement, and wasting. These mice also showed signs of blindness after 3 ± 4 days of Dox administration. This blindness might be attributed partly to the corneal hyperplasia (see below), and dramatic increase in the thickness of the eyelid skin (data not shown, and Xie et al., 1998) . The animals subjected to 5 ± 7 days of Dox induction died even when Dox was redrawn. In contrast, none of these features including the weight dierence were observed in the bitransgenic mice nor in the control animals (single transgenic or nontransgenic mice) in the absence of Dox (Figure 2) . These results and the histologic and molecular analyses described below suggest that the expression of ErbB2 transgene was stringently controlled in this Tet-On bitransgenic system by the presence or the absence of Dox.
Reversible doxycycline-induced and tissue-speci®c transgene expression Transgene expression was assessed by Northern blots on skin RNA. The probe was directed at the SV40 sequence located downstream of the sequences that encode both the rtTA and ErbB2. Similar levels of rtTA expression were detected in the skin of all K14-rtTA transgenic mice whether harboring this transgene alone or in combination with the TetRE-ErbB2 transgene. Expression of the K14-rtTA mRNA was independent of Dox treatment (Figure 3a , lanes 1, 3 and 4). Two rtTA speci®c transcripts of 1.9 kb and 1.4 kb were detected. The 1.9 kb band corresponds in size to the predicted mature mRNA encoded by the K14-rtTA transgene. The 1.4 kb band probably represents an alternatively spliced RNA. The identity of the rtTA transcripts was con®rmed by reprobing the membrane with the rtTA cDNA probe (data not shown). In contrast, no ErbB2 transgene expression was detected in the skin of the TetRE-ErbB2 single transgenic mice (lane 2), nor in the bitransgenic animal in the absence of Dox (lane 3). However, administration of Dox in drinking water (2 mg/ml) for 7 days in a 4-week-old bitransgenic animal (3-8-33), resulted in the robust expression of the 5.5 kb TetREErbB2 transgene in the epidermis (lane 4). To determine the level of induced transgene expression relative to the endogenous ErbB2 mRNA, the Northern blots were hybridized with the ErbB2 cDNA probe. As shown in Figure 3b , 4 days of Dox treatment in a 5-week-old bitransgenic mouse (3-8-110) resulted in an induction of the transgene ErbB2 such that the expression of the transgene ErbB2 was up to 20-fold higher than the endogenous message (4.5 kb) (lane 2). The induction of ErbB2 transgene expression did not signi®cantly alter the expression of endogenous ErbB2 gene (compare lane 1 and lane 2), in agreement with our previous report (Xie et al., 1998) .
The induction of ErbB2 transgene was restricted to the epidermis and other squamous epithelia (to be described). No transgenic ErbB2 transcripts were detected in the liver of bitransgenic mice treated with Dox, nor was rtTA expressed in the liver (Figure 3c , lane 6). The ErbB2 induction by Dox was rapid, and a signi®cant induction was achieved after 4 h of Dox administration ( Figure 3c , lane 2), with a plateau achieved by 24 h in the continuous presence of Dox (lanes 3 ± 5).
The Dox-induced expression of the ErbB2 transgene in the epidermis was completely reversible. A signi®cant reduction in ErbB2 transgene expression was observed 2 days after Dox withdrawal after an initial 2-day induction (data not shown), and by 7 days, no ErbB2 transgene mRNA was detected by Northern blotting, despite the continuous presence of rtTA expression (lanes 7 and 8). Animals treated for two days with Dox, then withdrawn from Dox for 7 derived from 20 mg of total RNA from each skin sample was subjected to Northern blot analysis. The ®lters were hybridized with 32 P-labeled SV40 probe (a and c), or the ErbB2 cDNA probe (b). The ®lters were subsequently stripped and reprobed with the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA as loading control (a and c). (a) Dox-induced ErbB2 transgene expression in the epidermis. The rtTA transcripts were detected in the skin of all K14-rtTA bearing animals (lanes 1 and 3, 4), while the expression of the 5.5 kb ErbB2 transgene was only observed in the bitransgenic mice in the presence of Dox (lane 4). The RNA in lane 5 was derived from a salivary tumor from a MMTV-ErbB2 transgenic mouse in which the ErbB2-SV40 poly (A) portion of the transgene is the same as in the TetRE-ErbB2 mice (Xie et al., 1998 , and reference therein). (b) A skin biopsy was obtained from a 5-week-old bitransgenic mouse (3-8-110) prior to the introduction of Dox in the drinking water (lane 1). The skin was sampled again after 4 days of Dox treatment (lane 2). The Northern blot analysis reveals that the expression of the ErbB2 transgene increased from undetectable to a level at least 20-fold higher than the endogenous ErbB2 mRNA. The induction of the ErbB2 transgene did not signi®cantly alter the expression of the endogenous ErbB2 message (compare lanes 1 and 2). (c) Time course and the reversibility of ErbB2 induction in bitransgenic mice. Time following the initiation of Dox treatment is shown on the ®gure. Lane 6 shows RNA derived from liver. The induction was completely reversed after withdrawal of Dox for 7 days following a 2-day Dox treatment (lanes 7 and 8 show RNA from two mice derived from two independent experiments), and the ErbB2 transgene was re-induced 1 day after Dox was added to the drinking water after a 7-day withdrawal (lane 9) days and ®nally treated again showed similar kinetics of induction (lane 9), further attesting to the relatively rapid reversibility and inducibility of transgene expression.
Histology of the epidermis and hair follicles of the Dox-induced adult bitransgenic mice
Histologic examination revealed that the skin from the back of the adult bitransgenic mice that had not been treated with Dox was indistinguishable from the skin of non-transgenic animals. The epidermis was uniform in thickness, consisting of one basal cell layer and 1 to 2 layers of suprabasal cells and there were readily recognized hair follicles (Figure 4a ). In contrast, the back skin from a 5-week-old bitransgenic mouse (3-8-110) treated for 4 days with Dox exhibited a hyperplastic epidermis with a nonuniform appearance with up to 8 ± 10 cell layers (Figure 4b ). The keratinocytes at each of the layers, and particularly the suprabasal cells, exhibited clear signs of hypertrophy. The spinous cells were two to three times the diameter of those in the control skin ( Figure 4b ). The number of hair follicles did not change signi®cantly, however, most of the follicles became very hyperplastic. Basal-like cells were present in the outer root sheath (ORS)-equivalent compartment, and morphologically more dierentiated spinous cell-like cells were present in the inner root sheath (IRS)-equivalent compartment ( Figure 4b ). The hair shafts were present in some of the hyperplastic follicles ( Figure  4b ). In addition, along much of the skin, there were numerous hyperproliferative intradermal squamous invaginations seen previously in the K14-ErbB2 model. This skin hyperplasia progressed rapidly in the continuous presence of Dox. Figure 4c is an example of severely aected skin in another 5-weekold bitransgenic animal (3-8-50) that had received 8 days of Dox induction. The hyperplasia is so severe that the dermal ®broblasts and collagen structure normally found in control animals of this age were no longer discernable. Similar abnormalities in skin and hair follicles were also detected in the skin from other areas of the body, including the head (data not shown). Collectively, these results demonstrate that the expression of rtTA in the epidermis by itself had no ill eect. Furthermore, in the absence of Dox, the expression of the ErbB2 transgene was minimal, both at the levels of detection by Northern blot analysis and phenotypic expression.
Figure 4 Skin histology. Hematoxylin and eosin-stained sections from the back skin of bitransgenic animals without Dox treatment (a) Dox-treated for 4, 8 and 2 days, respectively (b ± d), or 2 or 7 days after withdrawal of Dox after an initial 2-day treatment (e and f). Note the severe hyperplasia in epidermis and hair follicles (arrowhead), and the squamous invaginations in the Dox-induced skin (b). The hyperplasia after prolonged Dox induction was so severe that no discernable normal skin structures remained (c). Two days of Dox treatment caused thickened skin (d) the hyperplasia regressed signi®cantly 2 days after Dox withdrawal (e), and by 7 days, the hyperplasia was completely reversed (f, compared to the non-induced skin in a). Hf, hair follicle. Original magni®cation (a) and ( The epidermal hyperplasia was reversible if Dox was withdrawn within 2 ± 3 days. Two days of Dox administration resulted in a thickening of the epidermis of skin biopsied from the back of a 4-week-old bitransgenic mouse (Figure 4d ). In the biopsied skin of the same animal at 2 days after the withdrawal of Dox, the hyperplasia regressed significantly (Figure 4e ), and by one week after the withdrawal of Dox, the epidermis was indistinguishable from that of the control animals ( Figure 4f , compared to 4a). The kinetics of the regression of the hyperplasia correlated with that of the transgene expression described above.
The histological features of the neonatal skin of the bitransgenic animals after maternal administration of Dox were essentially the same as those observed in our previous K14-ErbB2 founder mice (Xie et al., 1998) . The most striking abnormality was the disruption of hair follicle morphogenesis. The majority of the hair follicles were replaced by hyperproliferative intradermal squamous invaginations, while the rest of the follicles exhibited severe hyperplasia and disorganization (data not shown, and Xie et al., 1998) .
Abnormalities in other strati®ed squamous epithelia
We investigated the eects of ErbB2 over-expression in strati®ed epithelia other than skin. An autopsy of a 5-week-old bitransgenic mouse treated for 8 days with Dox revealed massive hyperplasia, dyskeratosis, and irregularity in the esophageal epithelium (Figure 5b) . At most sites, the epithelium consisted of an many as 8 ± 10 cell layers, of which 3 ± 5 layers were basal-like cells (Figure 5b) , as opposed to a total of 3 ± 4 cell layers in the control littermate (Figure 5a ). The lumen of the esophagus was signi®cantly narrowed, perhaps blocked, as a result of the severe epithelial hyperplasia (Figure 5b ). Massive increases in epithelial thickness and irregularity were also observed in both dorsal ( Figure 5d ) and ventral (data not shown) portions of the tongue, compared to control animal (Figure 5c ). The hyperplasia of the epithelium in the esophagus and tongue may have aected the ability of the animal to swallow, thereby resulting in severe growth retardation (Figure 2) , the wasting symptoms, and eventual death.
Corneal hyperplasia was evident in the Dox-induced bitransgenic animals. The control neonatal corneal epithelium was uniform in thickness and consisted of two layers of epithelial cells (Figure 5e ). In contrast, a live-birth bitransgenic neonate born to a mother treated with Dox exhibited corneal epithelial hyperplasia with up to 5 ± 7 layers of cuboidal cells that were hypertrophic in appearance (Figure 5f ). Interestingly, the corneal stroma also exhibited changes with hypertrophic appearing ®broblasts and less organized collagen ®ber bundles. We believe these corneal stromal changes are an indirect consequence of ErbB2 over-expression in the corneal epithelium in that in situ hybridization revealed normal ErbB2 and TGFa expression in the corneal stroma ®broblasts (data not shown). The interdigitated corneal endothelial cells were apparently unaected.
With the exception of the cornea, the hyperplastic phenotypes were restricted to strati®ed epithelia as no appreciable histological abnormalities were observed in the simple epithelium of the lung and liver (data not shown). However, the hyperplasia was not observed in all of the strati®ed epithelial tissues; no apparent abnormalities were detected in the trachea and the forestomach (data not shown), consistent with the observation that K14 promoter is not active in these tissues (Wang et al., 1997) .
Correlation of cellular localization of the ErbB2 transgene expression and hyperplastic epithelia
To substantiate the interpretation that the epithelial hyperplasia in diverse epithelial tissues was attributed to the over-expression of the ErbB2 transgene, the cellular localization of the ErbB2 and rtTA transgene expression was examined by in situ hybridization using 35 S-labeled antisense riboprobes. The skin from the back of a 5-week-old nontransgenic mouse and bitransgenic animals that were treated or not treated with Dox were examined. In the nontransgenic skin, the endogenous ErbB2 was predominantly expressed in the outer root sheath (ORS) of the hair follicles ( Figure  6a , dark ®eld; see Figure 4a for morphology reference). A low-level of ErbB2 mRNA was also present throughout the interfollicular epidermis. The distribution of endogenous ErbB2 mRNA in the skin of adult animals was similar to that in neonatal mice (Xie et al., 1998) . The same pattern and intensity of ErbB2 expression were observed in the bitransgenic animals without exposure to Dox (data not shown), consistent with the Northern blot results (Figure 3a ) and the absence of skin abnormalities.
In contrast, a robust ErbB2 signal was detected in the hyperplastic epithelium from the back skin of a 5-week-old bitransgenic animal (3-8-110) that had been treated with Dox for 4 days. The ErbB2 mRNA was particularly abundant in the ORS-equivalent compartment of the hyperplastic hair follicles and in the basal layers of the epithelium (Figure 6b (see Figure 4b for morphology reference. Note the emulsion exposure time is 6 days in Figure 6b , compared to 14 days in Figure 6a ). High levels of rtTA mRNA expression, with the same cellular localization as ErbB2, was detected when the rtTA cRNA probe was utilized (Figure 6c , 6-day-exposure), con®rming the induction of the TetRE-ErbB2 transgene was under the directed control of rtTA in the presence of Dox. The expression of rtTA mRNA was also observed in the basal cells and ORS of the hair follicles in the K14-rtTA single transgenic mice, or the bitransgenic mice in the absence of Dox (data not shown), consistent with the Northern blot results (Figure 3a) . Collectively, these observations con®rm that the ErbB2 transgene is minimally expressed in the absence of Dox.
Using ErbB2 cRNA probe, we also proved for the expression of ErbB2 in the esophageal epithelium. The expression of ErbB2 in the esophagus of the mocktreated bitransgenic mouse was identical to that of nontransgenic animals; the erbB2 mRNA was detected predominantly in the basal cells (Figure 6d and e, bright-and dark-®eld, respectively). A signi®cantly elevated expression of the erbB2 transgene and expansion of transgene positive cells beyond the basal stratum were observed in the esophageal epithelium of (Figure 6f and g, bright-and dark-®eld, respectively). A similar induction of the erbB2 transgene expression, along with the presence of rtTA mRNA, were detected in the hyperplastic corneal epithelium from the bitransgenic neonates after maternal administration of Dox, and the severity of the corneal hyperplasia correlated with the expression levels of the ErbB2 transgene (data not shown). Thus, there is a direct linkage between the ErbB2 transgene expression with the hyperplastic phenotypes in diverse squamous epithelia. These results clearly demonstrate that targeted expression of the activated ErbB2 to sites in the epithelia where ErbB2 is normally expressed results in severe abnormalities in these tissues in neonates and in adult animals.
Aberrant keratin expression of the epidermis and corneal epithelium
We have previously demonstrated that the hyperplastic skin of K14-ErbB2 transgenic mice exhibited retarded ErbB2 induces reversible skin hyperplasia and TGFa W Xie et al and abnormal epithelial dierentiation by immunohistochemical staining with several antibodies that are either speci®c for proliferating cells or for key keratinocytes at various stages of squamous differentiation (Xie et al., 1998) . We performed a similar study in Dox-induced mouse tissues and control mouse tissues at neonatal and adult stages, and the results were identical to the previous investigation. Brie¯y, the adult skin from bitransgenic mice in the absence of Dox exhibited the same keratin expression pattern as the non-transgenic animals: K14, stained the singlelayered basal cells and in the ORS of the hair follicles; K10 was expressed in the 1 ± 2 layers of suprabasal cells of epidermis; ®laggrin was detected in the granular cells; and K16, a marker of hyperproliferation, was not found either in the epidermis nor in the follicles (data not shown, and Xie et al., 1998) .
The skin from the back of a 5-week-old Doxinduced transgenic mouse (3-8-110) exhibited strong K14 immunoreactivity in all cell layers of the epidermis and the hyperplastic follicles (Figure 7a ), while the K10 staining was so miminal in the suprabasal cells that positive cells were only detected focally (Figure 7b ). The ®laggrin expression was also signi®cant reduced, or even absent focally (Figure 7c ). K16 immunoreactivity was detected in many of the morphologically more dierentiated spinous cells in the center of the intradermal squamous invaginations, the inner root sheath equivalent compartment of the hyperplastic follicles, as well as the uppermost 2 ± 3 layers of the epidermis (Figure 7d) . Thus, the outermost several layers of keratinocytes in the transgenic skin simultaneously expressed K14, K10 and K16. Similar ketatin expression patterns were also observed in the skin from the Dox-induced neonatal skin (data not shown). These results demonstrate that there were severe defects in epithelial dierentiation as a result of ErbB2 overexpression even when the transgene was induced postnatally after the full development of the epidermis and hair follicles. S-labeled antisense riboprobes that correspond to the 2.7 kb NdeI ± SalI fragment of the C-terminal ErbB2 cDNA (a, b and d ± g) or the 1 kb full-length rtTA cDNA (c). After hybridization, sections were dipped in liquid emulsion and exposed for 14 days (a and d ± g), or 6 days (b and c) before developing. Original magni®cation, (a ± c), 1006; (d ± g), 2006
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We also characterized the hyperplastic cornea by using these markers. In the corneal epithelium of a control neonatal mouse, K14 stained the single basal cell layer (Figure 7e ), in agreement with the observation that the K14 promoter was active in cornea (Wang et al., 1997) while K10 was detected in the single layer of suprabasal cells (Figure 7g ). In the hyperplastic corneal epithelium of Dox-treated ani- (e ± h) expression of keratins in neonatal corneal epithelium. Cornea section of a control animal (e and g), or a Dox-inducing animal (f and h) were stained with anti-K14 (e and f), or anti-K10 antibody (g and h). (i ± k), analysis of epidermal proliferation by BrdU labeling and immunostaining. Paran sections from bitransgenic animals without Dox-treatment (i), with Dox-treatment (j, 3-8-110), or 7 days of drug withdrawal following 2 days of Dox-treatment (k). Note the increased BrdU labeling in the basal cells, and the expansion of BrdUpositive nuclei in the Dox-inducing skin (j), and by 7 days after Dox withdrawal (k), the BrdU labeling had no dierence from that of the non-induced skin (i). Original magni®cation, (a ± b), 2006; (e ± k), 4006 1 2 3 4 Figure 8 The up-regulation of TGFa and EGFR mRNA expression in ErbB2 transgene-expressing epidermis. (a) Northern blot analysis of TGFa expression and EGFR expression in the control, or the ErbB2-overexpressing tissues. Lane 1, mock-treated bitransgenic skin; lane 2, Dox-induced bitransgenic skin (lanes 1 and 2 are from the same blot as in Figure 3b , the membrane was stripped, and sequentially re-probed); lane 3, nontransgenic salivary gland; lane 4, salivary gland from the MMTV-ErbB2 transgenic mouse (from the same animal as in lane 5 of Figure 3a) . The blots were probed with the rat TGFa cDNA probe, stripped, and reprobed with mouse EGFR and murine GAPDH probes. The 4.8 kb TGFa transcripts (Bjorge et al., 1989) , and the 10 kb and 6 kb EGFR transcripts (Xie et al., 1997a) ErbB2 induces reversible skin hyperplasia and TGFa W Xie et al mals, strong K14 staining was observed in the basal and suprabasal cells with the exception of the single outmost layer of¯attened cells (Figure 7f ) while the K10 signal was detected only in the single outmost layer of cells (Figure 7h ). These results demonstrate that the ErbB2-induced dierentiation delay or arrest also takes place in this non-corni®ed strati®ed epithelium of the cornea.
Evidence for epidermal hyperproliferation
The thickened skin and the evidence of impaired keratinocyte dierentiation strongly suggested that conditional over-expression of activated ErbB2 in the epidermis induced a hyperproliferative state. To substantiate this interpretation, we preformed in vivo bromodeoxyuridine (BrdU) incorporation to examine DNA synthesis in the epidermis. Bitransgenic animals fed with either water or Dox-laced water were injected intraperitoneally with BrdU. After 2 h, tissue was then taken from the back skin, tongue, and esophagus. Paran sections were prepared for immunostaining with an anti-BrdU antibody. Under this in vivo labeling condition, 2 ± 5% of the basal cells were positive for BrdU incorporation in skin from the non-induced bitransgenic animal (Figure 7i ), similar to the frequency observed in nontransgenic animals (data not shown). In sharp contrast, the hyperplastic skin displayed 30 ± 40% BrdU-positivity in the nuclei of the basal cells and ORS after the mice had been fed for 4 days with Dox (Figure 7j ) when the erbB2 transgene was highly induced (Figure 6b ). Furthermore, a signi®cant number of BrdU-positive cells were detected beyond the basal stratum (Figure 7j ). Similarly increased BrdU labeling was also observed in the epithelium of the tongue and esophagus (data not shown). In agreement with the histological reversal ( Figure 4f ) seen following the shut o of ErbB2 transgene expression (Figure 3c ), BrdU labeling returned to control levels in the basal layer of the epidermis (Figure 7k ) 1 week after Dox withdrawal in animals receiving an initial 2-day exposure. Most of the hair follicles also returned to control levels although one follicle in panel 7k contains a few BrdU-positive cells. These patterns of BrdU immunostaining clearly demonstrated that over-expression of ErbB2 was associated with increased proliferation of the basal cells and an expansion of the proliferative compartment into the suprabasal strata.
Up-regulation of TGFa and EGFR mRNA expression in ErbB2-overexpressing epithelia
Activation of EGFR by EGF or TGFa upregulates the transcription of the TGFa gene (Coey et al., 1987; Bjorge et al., 1989) and its cognate receptor EGFR (Clark et al., 1985; Kudlow et al., 1986; Earp et al., 1986) . Because of the evidence for crosstalk among the ErbB family of RTKs (for review, see Carraway and Cantley, 1994; Dougall et al., 1994) , we examined whether the increased ErbB2 signaling caused an upregulation of endogenous TGFa and EGFR in the transgenic skin. After a 4-day Dox treatment, Northern blot analysis revealed an up to tenfold induction in TGFa mRNA expression in the skin of a 5-week-old bitransgenic mouse (3-8-110) (Figure 8a, lane 2) , as compared to a bitransgenic animal not exposed to Dox (lane 1). An induction in TGFa expression was also observed, though not as high, in adult bitransgenic animal after only 24 h of Dox treatment (data not shown). Northern blot revealed similar TGFa induction in neonatal ErbB2 transgenic skin (data not shown). The expression of EGFR was also elevated in the skin of Dox-fed bitransgenic animals although the induction was not as dramatic as the TGFa induction (Figure 8a) . Furthermore, the induction of both TGFa and EGFR exhibited tissue speci®city as no changes were observed in the ErbB2-induced hyperplasia of the salivary glands in the MMTV-ErbB2 transgenic mice (the generation of the MMTV-ErbB2 transgenic mice was described in Bouchard et al., 1989) , despite the high levels of transgene ErbB2 expression (Figure 3a, lane 5) .
The up-regulation of TGFa expression was further substantiated by in situ hybridization. Only very weak hybridization was seen in nontransgenic neonatal skin, and the endogenous TGFa did not appear particularly enriched in the basal cells and the ORS (Figure 8b and c, bright-and dark-®eld, respectively). In contrast, a signi®cant induction of TGFa mRNA was observed in the skin of a 1-day-old ErbB2 bitransgenic mouse born to mother fed with Dox ( Figure 8d and e, bright-and dark-®eld, respectively). The localization of TGFa mRNA was similar to that of the transgene ErbB2 (data not shown, and Xie et al., 1998) , indicating a direct association between the ErbB2 over-expression and the induction of TGFa mRNA. An induction of TGFa expression was also detected in hyperplastic epithelium from the back skin of Dox-fed adult bitransgenic animals (data not shown).
Discussion
In this report we describe the generation of a transgenic mouse system that allows the inducible expression of activated ErbB2 in the skin. To do so, we created two lines of transgenic mice. In one line we placed the reverse tetracycline activator, rtTA, under the control of the K14 promoter, and in the other, we placed ErbB2 under the control of the tetracycline response element. While rtTA was constitutively expressed in the basal cells of diverse strati®ed epithelia, the expression of the activated ErbB2 in these epithelial tissues of bitransgenic mice was suciently tightly inducible by Dox such that the dramatic phenotype, with its lethal outcome that was observed with constitutive expression of ErbB2 under the direct control of the K14 promoter, could be completely prevented by Dox withdrawal. This Tet-On system, by obviating the perinatal lethality experienced in our previous K14-ErbB2 model, allowed a detailed analysis of the consequences of ErbB2 activation, particularly in adult animals, on both corni®ed and non-corni®ed squamous epithelia, including skin, esophagus, tongue and cornea.
Over-expression of ErbB2 transgene causes severe phenotypes in multiple squamous epithelia Induction of ErbB2 transgene expression during embryonic development caused dramatic hair follicle ErbB2 induces reversible skin hyperplasia and TGFa W Xie et al abnormalities in neonates identical to that observed in the K14-ErbB2 neonates. The majority of the hair follicles were replaced by bizarre hyperproliferative intradermal squamous invaginations, while the rest of the follicles exhibited severe hyperplasia and disorganization (Xie et al., 1998) . The increased ErbB2 signaling during development did not cause simple skin overgrowth as no skin wrinkles were observed (data not shown, and Xie et al., 1998) . However, postnatal Dox treatment not only caused delayed dierentiation and hyperproliferative hair follicles and epidermis (Figure 7a ± h ), but also resulted in skin wrinkles due to skin overgrowth. Skin wrinkles were apparent when ErbB2 was induced in newborns through the feeding of Dox to their lactating mothers, or in weaned mice fed Dox directly in drinking water.
Based on both the K14-ErbB2 and the Dox-induced K14-rtTA/TetRE-ErbB2 transgenic mouse models, the skin and its appendages are clearly targets of K14-directed ErbB2 signaling. Additional target tissues were also revealed in this study, including cornea, tongue and esophagus; each developed massive hyperplasia upon Dox induction. However, trachea and forestomach were not aected. Invariably, the abnormal histology correlated with the high levels of ErbB2 mRNA ( Figure 6 , and data not shown). To our knowledge, no corneal abnormalities have been reported in previous K14 promoter-based transgenic mice over-expressing growth factors, cytokines, or oncogenes (Vassar and Fuchs, 1991; Cheng et al., 1992; Turksen et al., 1992; Davis et al., 1993; Guo et al., 1993; Arbeit et al., 1994; Williams and Kupper, 1994; Takahashi et al., 1994; Wysolmerski et al., 1994; Saito et al., 1995; Herber et al., 1996) . The corneal epithelial hyperplasia, together with the thickness of eyelid skin, probably accounted for the blindness that occurred in adult bitransgenic mice after 3 ± 4 days of Dox administration. Hyperplasia of the tongue and esophagus, which were observed in our previously described K14-ErbB2 model, but to a lesser degree (Xie et al., 1998) , may have prevented the animals from feeding, resulting in a wasting syndrome and death. This wasting syndrome was reminiscent of metabolic disorders. Although a thorough investigation was not carried out, one suspect was the hypercalcemic syndrome resulting from overexpression of the parathyroid hormone related protein (PTHrP), which is normally expressed in keratinocytes (Wysolmerski et al., 1994 , and our own observation). However, we observed no induction of PTHrP expression in the ErbB2-induced hyperplastic keratinocytes based on Northern blot analysis, nor were the animals hypercalcemic (data not shown). Over-expression of ErbB2 has been reported in advanced human esophageal carcinomas, and in some cases, this overexpression is associated with the elevated expression of the EGFR and Grb7, a substrate of the EGFR and ErbB2 (Tanaka et al., 1997) . In this report, in situ hybridization detected the expression of endogenous ErbB2 in the esophageal epithelium with predominant distribution in the basal cells, suggesting a role for ErbB2 signaling in the normal physiology of the esophageal epithelium. Robust expression of the ErbB2 transgene (Figure 6g ) and the resultant massive hyperplasia (Figure 5b) were detected in the esophageal epithelium of the Dox-induced bitransgenic animals, further supporting the involvement of ErbB2 signaling in this tissue, and the potential contribution of increased ErbB2 signaling in the pathogenesis of esophageal carcinomas.
Over-expression of ErbB2 transgene causes an upregulation of TGFa and EGF receptor
In our previously described transgenic mouse model, in which ErbB2 was constitutively overexpressed in the skin, no evidence of lateral skin overgrowth was observed, in that these mice exhibited no skin wrinkling. However, skin overgrowth and wrinkling was associated with another model, the K14-TGFa mouse (Vassar and Fuchs, 1991) . As reviewed previously (Xie et al., 1998) , the K14-ErbB2 mouse shares several features with the K14-TGFa mouse. A major dierence, however, was that the K14-TGFa mouse was viable, perhaps allowing the post-natal development of the overgrowth feature while the K14-ErbB2 mouse was not viable. In contrast, the bitransgenic mice, in which ErbB2 expression was induced postnatally, did develop skin wrinkling. The ®nding of wrinkling prompted us to determine whether the postnatal induction of ErbB2 in the bitransgenic mouse model was associated with changes in the expression of TGFa or the EGFR. Such changes could amplify the eects of ErbB2 overexpression by increasing signaling through this other ErbB family member. Indeed, we found that induction of ErbB2 expression in bitransgenic mice was followed, within 24 h of the initiation of Dox feeding, by a marked increase in the expression of both TGFa and the EGFR. This increase in TGFa expression (within 24 h of Dox treatment) preceded the hyperplastic changes (after 2-day-exposure of Dox) in the skin and occurred in the same cells in which ErbB2 overexpression was induced. This change in TGFa and EGFR expression was relatively speci®c in that the expression of PTHrP, another molecule expressed in the keratinocytes, did not change following the induction of ErbB2 expression. Furthermore, the induction of TGFa expression was not necessarily due to a relative expansion of the basal cell population, since the basal cells are normally not particularly enriched for TGFa expression as judged by in situ hybridization (Figure 9c ). While our result does not completely rule out the possibility that the observed induction of TGFa was a consequence of hyperplasia and change in the relative population of cells in the skin, it suggests that the induction of TGFa expression was a consequence of increased ErbB2 signaling. There are several possible but not mutually exclusive explanations to account the TGFa upregulation by ErbB2. First, the increased ErbB2 signaling may have caused a pleiotropic response, and in turn may have activated the TGFa transcription via yet to be characterized mechanisms. Alternatively, increased ErbB2 signaling may have caused the activation of EGFR signaling system, which in turn up-regulates the transcription of TGFa. This possibility is consistent with in vitro cell culture results, in which EGF or TGFa stimulates the accumulation of mRNA for TGFa in human keratinocytes (Coey et al., 1987) , or breast cancer cells (Bjorge et al., 1989) . However, the K14-TGFa mouse did not exhibit upregulation of endogenous EGFR expression (Vassar and Fuchs, 1991) . Regardless of the mechanism, it is tempting to speculate that the activation of the EGFR through upregulation of the expression of both itself and its ligand, TGFa, could amplify ErbB2 signaling as a result of lateral interaction between the ErbB2 and EGFR as suggested by cell culture studies (for review, see Carraway and Cantley, 1994; Dougall et al., 1994) . This amplication of the ErbB2 signal by upregulation of TGFa may have contributed to the severe hyperplasia observed in the strati®ed tissues of the K14-ErbB2 mice and the Dox-induced bitransgenic animals. Interestingly, TGFa and EGFR expression were not up-regulated in the ErbB2-induced hyperplasia of the salivary glands (Figure 8a ), suggesting some degree of tissue-speci®city in response to increased ErbB2 signaling as we had proposed previously (Xie et al., 1998) .
The dierence in the range and severity of the phenotypes between our previous and the current transgenic mice models suggest that there might be some subtle dierences in ErbB2 signaling during development and post development. Alternatively, the expression level of ErbB2 transgene is more elevated in the bitransgenic model system than the previous K14-ErbB2 system, because the transgene expression is not directly dependent on the K14 promoter strength, but was ampli®ed through the transactivator rtTA. Lastly, considering the kinetics of ErbB2-induced lethality in the bitransgenic animals, it cannot be ruled out that not one, but both of our previous K14-ErbB2 founder mice that survived beyond 3 weeks were chimeric with regionally restricted skin hyperplasia and papilloma formation (Xie et al., 1998) .
The Tet-On system has many attributes Perinatal lethality, which would limit the analysis of the gene function, is not unusual when a oncogene or growth factor gene is targeted to the epidermis of transgenic animals (Bailleul et al., 1990; Xie et al., 1998) . Indeed, the concept of conditional expression was conceived to overcome the many potential circumstances of embryonic and perinatal lethality that accompanies changes in expression of many important genes. Tetracycline/Doxycycline regulated systems appear to provide a solution. Thus far, all of the published applications have made use of the Tet-O system, in which the transgene expression can be turned o in the presence of Dox (Efrat et al., 1995; Ewald et al., 1996; Mayford et al., 1996; Yu et al., 1996; Mansuy et al., 1998) . None of these examples was applied to a transgene with embryonic or perinatal lethality. Furthermore, there has been some suspicion that the Tet-On system might allow a sucient level of basal expression in the absence of Dox such that the lethal phenotype might not be obviated. While our experiments were not designed primarily to test the Tet-On system for such a problem, our use of the lethal ErbB2/ skin system suggests that gene expression with the TetOn system does exhibit sucient dependence on the presence of Dox, such that neither the lethal phenotype is expressed nor is there detectable expression of the ErbB2 transgene in the absence of Dox.
Tet-On and Tet-O systems both take advantage of the pharmacologic properties that Dox can cross placental barrier, allowing the study of the eects of toxic genes during embryogenesis, and that Dox is secreted into milk, allowing the induction of the transgene in neonates. But the Tet-On system has additional attractive attributes from the kinetics of induction relative the Tet-O system. Induction by Dox is rapid. Transgene expression was detected at 4 h, and reached a maximum at 24 h after exposure to Dox (Figure 3) . Induction is also rapidly reversible, requiring 2 ± 3 days for reversal of the phenotype. In contrast, the Tet-O system requires 4 ± 7 days of the continuous presence of Dox (Kistner et al., 1996; Mayford et al., 1996) to shut down tTA-dependent transcription and also requires the cessation of Dox for days before gene expression is fully induced, even in an animal that has previously been fed with low doses of Dox to suppress gene expression (Kinstner et al., 1996) . Another advantage of the Tet-On system is that it is convenient and cost-eective, especially if a transgene is embryonically or perinatally toxic. While the Tet-o system requires maternal supplementation of Dox throughout gestation and postnatally in order to keep the transgene o, the Tet-On system does not require this eort and expense. Our demonstration of the usefulness of the Tet-On system for the conditional expression of a lethal transgene should encourage the use of this system for the generation of other models.
Materials and methods
Generation and identi®cation of transgenic mice
Two transgenic constructs, TetRE-ErbB2, and K14-rtTA, were utilized in this Tet-On system. To generate TetREErbB2 transgene, the 6.2 kb HindIII ± EcoRI fragment containing the activated form of rat c-neu/erbB2 cDNA and SV40 intron/poly(A) sequence was released from K14-ErbB2 transgene construct (Xie et al., 1998) , and placed downstream of the 439 bp Tet-responsive P hCMV*71 promoter from the pTetRE plasmid (Clontech, Palo Alto, CA, USA), which contains the minimal CMV promoter fused with Tetresponsive element (TER). To generate K14-rtTA transgene, the ErbB2 cDNA in the K14-ErbB2 transgene (Xie et al., 1998) was replaced by the 1025 bp reverse tet-responsive transcriptional activator (rtTA) from the pTet-On vector (Clontech). The 6.6 kb TetRE-ErbB2, and the 4.9 kb K14-rtTA transgenes were excised from the vector, and puri®ed from agarose gel using QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA, USA). Microinjection of transgene into one-cell B66SJL mouse zygotes at a concentration of 2 ng/ml was carried out at the University of Alabama at Birmingham Transgenic Animal Facility. All mice were handled in an accredited university facility in accordance with the institutional animal care policies.
Genomic DNA was isolated as described before (Xie et al., 1997a) . The polymerase chain reaction (PCR) was used to screen the transgene positive mice. The TetRE-ErbB2 mouse screening was carried out as described before (Xie et al., 1998) . Two oligonucleotides were used to PCR-screen K14-rtTA mice, one oligonucleotide annealing to rtTA cDNA (Clontech), 5'-CGCCATTATTACGACAAGCT-3', and the other oligonucleotide to the SV40 sequence downstream of the transgene in the expression cassette, 5'-GTCCTTGGGGTCTTCTACCTTTCTC-3'. PCR was carried out in a DNA thermal cycler (Perkin-Elmer/Cetus, Norwalk, CT, USA) using the following program: 948C for 1 min, 588C for 2 min, and 728C for 3 min, and products were analysed by electrophoresis on a 1% agarose gel. The transgene integration status was analysed by Southern blot.
ErbB2 induces reversible skin hyperplasia and TGFa W Xie et al Ten microgram of mouse tail genomic DNA was digested with SalI restriction enzymes, and subjected to Southern blotting and hybridization using Hybond-N + nylon membrane (Amersham). The probes used were the 32 P-labeled 1.9 kb HindIII ± NdeI ErbB2 cDNA (for TetRE-ErbB2 transgene), the 1 kb EcoRI ± BamHI rtTA cDNA (for K14-rtTA transgene), or the transgene-speci®c SV40 SalI ± EcoRI fragment (for both transgenes).
Doxycycline administration
Doxycycline (Sigma, St. Louis, MO, USA) was diluted in 5% sucrose in water to a ®nal concentration of 2 mg/ml, and supplied as drinking water. The Dox-containing water was unlimited, and was changed every 2 ± 3 days.
Northern blot analysis
Total RNA was prepared from the tissues using the guanidine isothiocynate extraction method, as previously described (Xie et al., 1997b) . In some cases, poly(A) RNA puri®ed the Oligtex mRNA Kit (QIAGEN) was utilized. In addition to probes described in Southern blot, other probes utilized were the 0.7 kb rat TGFa cDNA and the 2.3 kb mouse EGFR cDNA probes (Xie et al., 1997a) . The ®lters were subsequently stripped and rehybridized with a plasmid containing a murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA for RNA loading normalization. In some cases, signal quanti®cation was performed using CCD Video Camera Module, in conjunction with NIH Image 1.61 software.
Histologic evaluation, BrdU labeling and immunohistochemistry
Gross and microscopic evaluation were performed. Tissues were ®xed in 4% formaldehyde in 16PBS, embedded in paran, sectioned at 5 mm, and stained with hematoxylin and eosin for histological examination. In vivo BrdU labeling was performed by intraperitoneal injection of BrdU as described (Xie et al., 1997a) . Mouse skin biopsies were performed under mild anaesthesia.
Formaldehyde ®xed and paran embedded sections (5 mm) were prepared and immunostained with a rat monoclonal anti-BrdU antibody MSA250P (1 : 200) (Accurate, Westbury, NY, USA) using Vectastain Elite ABC Kit (Vector, Burlingame, CA, USA). Three prime diaminobenzidine tetrahydrochloride (DAB) was used as the chromogen, and sections were counterstained with Gill's Hematoxylin (Vector). To facilitate BrdU detection, sections were pretreated with 2 N HCl for 20 min at 378C, and exposed to 0.01% trypsin at 378C for 3 min (Xie et al., 1997a) . Immunohistochemical detection of keratins was performed as described (Cheng et al., 1995) . The primary antibodies and their dilutions are: mouse monoclonal anti-K14, 1 : 20; mouse monoclonal anti-K10, 1 : 50; mouse monoclonal anti-K16, 1 : 40 (all from Novocastra Laboratories, Burlingame, CA, USA), and mouse monoclonal anti-®laggrin, 1 : 100 (Biomedical Technologies, Stoughton, MA, USA). The detection system and counterstain were the same as BrdU immunostaining as described above.
In situ hybridization
Frozen sections (10 mm) were utilized. The probes were the 2.7 kb NdeI ± SalI ErbB2 cDNA C-terminal fragment, or the 1 kb rtTA cDNA. The 35 S-UTP labeled antisense cRNA riboprobe preparation and hybridization were carried as described (Xie et al., 1998) . After hybridization, emulsion dip, exposure and developing, the sections were counterstained with hematoxylin and eosin, and subjected to microscopic examination under bright-and dark-®eld illumination.
